|
|
|
|
| LEADER |
01663nam a2200289 u 4500 |
| 001 |
EB000942483 |
| 003 |
EBX01000000000000000736073 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 0309100569
|
| 020 |
|
|
|a 9780309100564
|
| 050 |
|
4 |
|a RM265.2
|
| 245 |
0 |
0 |
|a Treating infectious diseases in a microbial world
|h Elektronische Ressource
|b report of two workshops on novel antimicrobial therapeutics
|c Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials, Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation, Board on Life Sciences, Division on Earth and Life Sciences, National Research Council of the National Academies
|
| 260 |
|
|
|a Washington, DC
|b National Academies Press
|c 2006, c2006
|
| 300 |
|
|
|a x, 92 p.
|b ill.
|c 23 cm
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Bacterial Infections / drug therapy
|
| 653 |
|
|
|a Anti-Infective Agents / therapeutic use
|
| 653 |
|
|
|a Infections / drug therapy
|
| 710 |
2 |
|
|a National Research Council (U.S.)
|b Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials
|
| 710 |
2 |
|
|a National Research Council (U.S.)
|b Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u http://fermat.nap.edu/books/0309100569/html
|3 Volltext
|n Provider site
|3 Volltext
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK19849
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|